U.S. BancorpNYSE: USB
Financials · Diversified Banks
$58.99
+8.12%
Vol: 988K
Research Digest
Monday, June 15, 2026
No significant overnight updates
No material news in the last 48 hours.
Previous Market Intelligence
13 daysJun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21U.S. Bancorp shares rose 1.86% on May 20 to $54.29 as Amazon Business Card partnership and new SMB lending products expand fee revenue.Positive▶
U.S. Bancorp climbed 1.86% on May 20 to close at $54.29 as investors digested the recently announced Amazon Business Card partnership, with Amazon launching new no-annual-fee Prime Business and Amazon Business cards issued by U.S. Bank on the Mastercard network. The bank also launched a new loan product targeted at startup dental and veterinary practices on May 11. U.S. Bancorp issued a series of senior and subordinated fixed-income securities with maturities into the 2040s. Q1 2026 EPS was $1.18 on $7.3B revenue, beating consensus and growing revenue 4.7% YoY. The average 12-month analyst price target stands at $63.48 with 13 buy and 1 sell ratings.
May 20U.S. Bancorp launched co-branded Amazon Prime Business and Amazon Business credit cards, displacing American Express as issuer in a meaningful expansion of its card franchise.Positive▶
U.S. Bancorp announced it has taken over from American Express as the issuer of the Amazon Prime Business Card and Amazon Business Card, with new co-branded products targeting SMB customers seeking rewards, financing, and spend management for Amazon purchases. The win deepens USB's existing Amazon and Mastercard relationships and adds a new lever to its valuation story. The bank also rolled out new startup loans for dental and veterinary practices in May 2026. USB shares closed May 18 at $53.45 (+0.6%), but were down about 4.8% over the prior 30 days versus an analyst consensus target near $63. JPMorgan trimmed its target to $57.50 (from $58) on April 30, while Evercore ISI raised to $60 (from $58). The stock pays a 3.88% dividend yield with a P/E around 11.
May 19U.S. Bancorp issued $7.465 million in 5.625% senior medium-term notes maturing May 2041 and launched a startup-practice loan product for dentists and veterinarians, while JPMorgan reaffirmed its Sell-equivalent rating with a $57.50 price target.Mixed▶
U.S. Bancorp continued executing growth initiatives in mid-May 2026, launching a new loan product targeting first-time dental and veterinary practice startups on May 11, and expanding its co-brand business credit card partnership with Amazon and Mastercard. The bank also issued senior medium-term notes carrying a 5.625% fixed coupon maturing in 2041 with an issuer call beginning August 2028. JPMorgan trimmed its price target to $57.50 from $58 while reaffirming an Underweight/Sell-equivalent stance. Shares traded around $52-53 on May 18, with the stock falling 3.2% on May 13. The bear case: regional banks remain highly sensitive to deposit competition and credit trends; JPMorgan's continued Sell-equivalent rating signals concerns about growth potential and valuation, and incremental long-dated debt at 5.625% increases funding costs versus core deposits.
May 18US Bancorp launched a marquee Amazon co-branded business credit card partnership, replacing American Express as issuerPositive▶
On May 13, 2026 U.S. Bancorp and Amazon launched new co-branded Prime Business Card and Amazon Business Card products, with USB replacing American Express as the issuer in partnership with Mastercard. The cards offer enhanced rewards and flexible financing for Amazon Business customers, expanding USB's commercial card footprint. On May 11, U.S. Bank also launched a new loan product for startup dental and veterinary practices and released its CFO Survey covering geopolitics and inflation. Q1 2026 EPS came in at $1.18 vs. consensus of $1.14, a 3.51% beat; next earnings are scheduled for July 16, 2026 with consensus EPS of $1.25. USB closed at $53.12 on May 15, down 4.8% over the prior 30 days and trading at a P/E of 11.13 with a 3.9% dividend yield. Analyst consensus is Buy (13 buys, 1 sell).
May 15U.S. Bancorp launched startup loans for dentists and veterinarians on May 11 and is pricing 20-year senior callable notes at 5.625% with May 19 pricing date.Neutral▶
U.S. Bancorp introduced a loan product for first-time-practice dentists and veterinarians on May 11. The bank is offering 20-year senior callable notes due May 21, 2046 at a 5.625% fixed coupon with calls beginning May 21, 2031, with a Pricing Date expected May 19. The stock trades around $54.80 with 13 analyst Buy ratings vs 1 Sell. JPMorgan recently lowered the PT to $57.50 from $58 (April 30). Q1 EPS of $1.18 beat estimates of $1.14.
May 14U.S. Bancorp expanded payments and capital markets via Elavon SMB and the pending BTIG acquisition while shares fell 3.2% on May 13Mixed▶
U.S. Bancorp closed at $52.74 on May 13, 2026, down 3.19%, even after a strong year-to-date performance. The bank continues to widen its payments reach through Elavon's SMB platform and its pending BTIG acquisition, which will deepen capital markets capabilities. In early May, U.S. Bank launched new startup loan products targeting dentists and veterinarians opening first-time practices. The latest U.S. Bank CFO Insights Report showed 49% of finance leaders expect more acquisitions over the next 12 months. Q1 2026 EPS of $1.18 beat the $1.14 estimate, with 17% return on tangible common equity. Consensus 12-month price target is $63.48, with 13 Buys and 1 Sell.
May 13U.S. Bancorp launched a startup loan program for dentists and veterinarians and is pricing 20-year callable notes at 5.625% next week.Mixed▶
On May 11, 2026, U.S. Bank announced a startup loan product for dentists and veterinarians launching first-time practices, expanding its specialty-vertical lending. U.S. Bancorp is pricing 20-year callable notes at 5.625% with pricing date May 19 and issuance May 21. The company released its latest CFO Insights Survey on May 12, with 39% of CFOs ranking cost cutting as top priority. JPMorgan cut its PT to $57.50 from $58 (Sell) on April 30; Evercore ISI raised to $60 from $58 on April 29; Oppenheimer maintained Buy on April 25. Q1 2026 beat Wall Street with reaffirmed full-year guidance.
May 12U.S. Bancorp prices $22.5M callable senior medium-term notes at 6.00% coupon maturing May 2046 amid Q1 EPS beat of $1.18.Positive▶
U.S. Bancorp priced $22,492,000 of callable Senior Medium-Term Notes at a 6.00% coupon maturing May 13, 2046, with quarterly call dates beginning May 13, 2027. Q1 2026 results delivered EPS of $1.18 (beating $1.14 consensus by 3.51%) with revenue of $7.3B up 4.7% YoY; net interest income rose 4.1% to $4.3B and fee income jumped 6.9% YoY. The bank reported a 13.6% jump in Q1 profit on higher interest income and fee revenue. Strategic initiatives include Amazon co-brand partnership for small business reach and ongoing BTIG acquisition integration. New insider activity included a Senior EVP selling $1.9M in stock in early May. Analyst consensus is Moderate Buy with average 12-month PT of $63.18. Shares trade near $54.49 on May 11.
May 11No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 8US Bancorp Q1 EPS of $1.18 (+15% YoY) beat expectations with 4.7% revenue growth; new cash flow platform launched for small businessesPositive▶
US Bancorp reported Q1 2026 EPS of $1.18 (up 15% YoY) with $7.3B revenue (up 4.7%). Net interest income grew 4.1% supported by robust loan growth. Company appointed Toby Clements as Chief Operations Officer. Launched comprehensive cash flow platform for SMB clients. Analysts maintain Buy rating with $60.25 price target (+7% upside). Recent analyst downgrades cited NIE and buyback concerns.
May 6Q1 EPS up 15% to $1.18; new COO Toby Clements appointed; strong operational performance.Positive▶
US Bancorp reported strong Q1 2026 with diluted EPS of $1.18 (up 15% YoY) and total net revenue of $7.3B (up 4.7% YoY). Toby Clements appointed senior EVP and chief operations officer effective April 13, overseeing 16,000+ employees in client service centers and operations. Launched comprehensive cash flow management platform for small businesses; signed as NFL's official bank and wealth management partner. Recent analyst moves: Oppenheimer raised PT to $73 from $71; JPMorgan lowered to $57.50 reaffirming Sell. 12-month consensus PT $60.25 suggests 7% upside from $55.60 current price. Solid fundamentals offset mixed analyst sentiment.
May 5US Bancorp reports strong Q1 with 15% EPS growth, becomes NFL banking partnerPositive▶
U.S. Bancorp delivered Q1 2026 earnings per share of $1.18, up approximately 15% year-over-year, with total net revenue of $7.3 billion increasing 4.7% year over year. The company signed NFL partnership for bank and wealth management services and launched a comprehensive cash flow management platform for small businesses. CEO Gunjan Kedia added board chair title, returning to former governance structure.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| JPMJPMORGAN | $322.55 | +6.45% | +0.8% | 12.9x | 1.02 | $811.9B |
| BACBANK | $56.23 | +9.20% | +1.6% | 10.2x | 1.22 | $365.4B |
| WFCWELLS | $84.40 | +11.17% | +2.1% | 9.7x | 0.96 | $232.3B |
| CCITIGROUP | $142.07 | +13.45% | +2.3% | 10.0x | 1.12 | $213.6B |
| PNCPNC | $236.74 | +8.41% | +2.2% | 10.4x | 0.93 | $87.7B |
| USBUS | $58.99 | +8.12% | +2.1% | 9.7x | 1.02 | $84.7B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price above both MAs — bullish structure.